Efficacy of rituximab on pulmonary nodulosis occurring or increasing in patients with rheumatoid arthritis during anti-TNF-α therapy

Clinical and Experimental Rheumatology

Volumn 29, Issue 4, 2011, Pages 752-753

  De Stefano, R ^a   Frati, E ^a   Nargi, F ^a   Menza, L ^a  

^a UNIVERSITY OF SIENA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; ETANERCEPT; LEFLUNOMIDE; METHOTREXATE; RITUXIMAB; TUMOR NECROSIS FACTOR ALPHA INHIBITOR; ANTIRHEUMATIC AGENT; IMMUNOGLOBULIN G; MONOCLONAL ANTIBODY; TNFR FC FUSION PROTEIN; TNFR-FC FUSION PROTEIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

ADULT; AGED; CASE REPORT; DRUG EFFICACY; DRUG WITHDRAWAL; FEMALE; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; LETTER; LUNG NODULE; MALE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; RHEUMATOID NODULE; CHEMICALLY INDUCED DISORDER; COMPUTER ASSISTED TOMOGRAPHY; DRUG ANTAGONISM; DRUG SUBSTITUTION; IMMUNOLOGY; METABOLISM; MIDDLE AGED; MULTIPLE PULMONARY NODULES; RADIOGRAPHY; TREATMENT OUTCOME;

AGED; ANTIBODIES, MONOCLONAL; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; DRUG SUBSTITUTION; FEMALE; HUMANS; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; MULTIPLE PULMONARY NODULES; RECEPTORS, TUMOR NECROSIS FACTOR; RHEUMATOID NODULE; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 80055116749     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Letter

References (10)

1. CUNNANE G, WARNOCK M, FYE KH, DAIKH DI: Accelerated nodulosis and vasculitis following etanercept therapy for rheumatoid arthritis. Arthritis Rheum 2002; 47: 445-9.
2. KEKOW J, WELTE T, KELLNER U, PAP T: Development of rheumatoid nodules during anti-tumor necrosis factor alpha therapy with etanercept. Arthritis Rheum 2002; 46: 843-4.
3. HÜBSCHER O, RE R, IOTTI R: Pulmonary rheumatoid nodules in an etanercept-treated patient. Arthritis Rheum 2003; 48: 2077-8.
4. VAN EDE AE, DER BROEDER A, WAGENAAR M, VAN RIEL, CREEMERS MC: Etanercept-related extensive pulmonary nodulosis in a patient with rheumatoid arthritis. J Rheumatol 2007; 34: 1590-2.
5. WATSON P, SIMLER N, SCREATON N, LILLICRAP M: Management of accelerated pulmonary nodulosis following etanercept therapy in a patient with rheumatoid arthritis. Rheumatology 2008; 47: 928-9.
6. TOUSSIROT E, BERTHELOT JM, PERTUISET E et al.: Pulmonary nodulosis and aseptic granulomatous lung disease occurring in patients with rheumatoid arthritis receiving tumor necrosis factor-alphablocking agent: a case series. J Rheumatol 2009; 36: 2421-7
7. BASS AR, SCHNEIDER R, SANDERS A, FLIEDER D, NATHAN CF, ERKAN D: Pulmonary nodules in an infliximab-treated rheumatoid arthritis patient: a clinical pathology conference held by the Division of Rheumatology at Hospital for Special Surgery. HSS J 2007; 3: 119-25.
8. DEROT G, MARINI-PORTUGAL A, MAITRE B, CLAUDIEPIERRE P: Marked regression of pulmonary rheumatoid nodules under etanercept therapy. J Rheumatol 2009; 36: 469-71.
9. BAETEN D, DE KEYSER F, VEYS EM, THEATE Y, HOUSSIAU FA, DUREZ P: Tumor necrosis factor alpha independent disease mechanisms in rheumatoid arthritis: a histopathological study on the effect of infliximab on rheumatoid nodules. Ann Rheum Dis 2004; 63: 489-93.
10. OQUEDA T, SCHULTZ H, MOOSIQ F: Favorable response of pulmonary rheumatoid nodule to Rituximab. Rheumatol 2009; 68: 343-4.